The Fire of Ivermectin: How It’s Changing the USA Healthcare Debate
In 2025, Ivermectin USA has reignited fierce debates across the healthcare landscape. Once a niche antiparasitic drug, Ivermectin’s resurgence has sparked conversations involving patients, healthcare providers, insurers, and lawmakers alike.…